CP
Celon Pharma SA
šµš±XWAR.CLNPolandHealthcare
PLNĀ 21.80PLNdown -0.20 (-0.91%)OpenEnd of day11:49 AM
PricePLNĀ 21.80-0.20 (-0.91%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Poland
Identity
- Exchange
- Warsaw Stock Exchange . XWAR
- Type
- Stock
- ISIN
- PLCLNPH00015
- CUSIP
- Not reported
Company
- Employees
- 564
- Headquarters
- Lomianki, Poland
- Website
- https://www.celonpharma.com
- CEO
- Dr. Maciej Wieczorek Ph.D.
Market
- Shares outstanding
- 38.9M
- Market cap
- PLNĀ 848.27M
Highlights
- Market cap
- PLNĀ 848.27M
- EPS LTM
- PLNĀ 2.04
- P/E LTM
- 9.68
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- PLNĀ 219.8M+15.14%up year on year
- Net income
- PLNĀ 108.6M+347.58%up year on year
- Gross margin
- 27.76%-56.38%down year on year
- Free cash flow
- -PLNĀ 34.61M+19.79%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.